+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-helminthic Drugs Market - Global Forecast 2026-2032- Product Image
Anti-helminthic Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Anti-helminthic Drugs Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6143047
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anti-helminthic Drugs Market is projected to reach USD 2.93 Billion in 2026. It is expected to continue growing at a CAGR of 5.21%, reaching USD 4.03 Billion by 2032.

Anti-helminthic Drugs: Executive Summary and Market Context

Anti-helminthic drugs are medicines used to prevent or treat infections caused by parasitic worms, including nematodes, cestodes, and trematodes. Their public-health importance is greatest where sanitation gaps, contaminated soil or water, foodborne exposure, and limited access to diagnosis allow helminth infections to persist. The landscape includes human and veterinary applications, preventive chemotherapy, targeted treatment, and combination approaches. Demand is shaped by disease burden, treatment guidelines, medicine availability, resistance monitoring, procurement systems, and progress in water, sanitation, and hygiene.

How Diagnosis, Prevention, and Resistance Are Reshaping Helminth Control

The field is shifting from periodic treatment alone toward integrated control programs that combine preventive chemotherapy with improved diagnosis, sanitation, health education, and surveillance. More sensitive testing is supporting better identification of low-intensity and species-specific infections, while digital records and program data can improve treatment targeting and follow-up. At the same time, repeated use of a limited set of medicines has increased attention to reduced susceptibility and the need for pharmacovigilance, therapeutic monitoring, combination strategies, and stewardship. Regulatory expectations are also emphasizing product quality, pediatric suitability, access, and evidence of use in underserved populations.

Artificial Intelligence Is Strengthening Detection, Stewardship, and Program Design

Artificial intelligence can support anti-helminthic drug programs by helping interpret diagnostic images, prioritize populations for screening, identify adherence risks, and analyze geographic or clinical surveillance data. Machine-learning tools may also assist drug discovery, compound screening, formulation development, and prediction of resistance-related patterns. Their value depends on representative datasets, independent validation, explainability, cybersecurity, and integration with laboratory and public-health workflows. AI should augment clinicians and program managers rather than replace confirmatory testing, safety review, or medical judgment.

Regional Insights: Uneven Disease Burden Requires Locally Adapted Strategies

North America generally emphasizes travel-associated disease, immigrant and refugee health, veterinary transmission, and access to specialist diagnosis, with surveillance and laboratory confirmation supporting targeted treatment. Latin America combines persistent soil-transmitted and foodborne helminth risks with important rural and underserved populations, making school-based delivery, sanitation, and cross-border coordination relevant. Europe focuses on imported infections, localized transmission, food safety, and drug stewardship, while health systems support stronger diagnostic infrastructure. The Middle East faces varied exposure patterns linked to water, migration, and displacement. Africa remains central to global helminth-control efforts because many communities face substantial endemic burden and access constraints. Asia-Pacific spans highly diverse settings, from advanced health systems managing imported or localized disease to areas where mass drug administration, sanitation, and rural outreach remain essential.

Group Insights: Multilateral and Economic Blocs Shape Access and Coordination

ASEAN countries benefit from coordinated attention to tropical disease surveillance, cross-border mobility, and supply continuity, but implementation differs substantially across health systems. BRICS members span major endemic populations, manufacturing capabilities, and research capacity, creating opportunities for cooperation on affordable medicines, diagnostics, and surveillance. The European Union supports regulatory alignment, cross-border health coordination, and antimicrobial-resistance expertise. G7 members contribute advanced research, financing, procurement, and global-health partnerships, while also managing imported infections and vulnerable populations. GCC states combine strong clinical infrastructure with high mobility and migrant-worker health considerations. NATO members may benefit from interoperable medical planning, preparedness, and deployment-oriented infectious-disease surveillance, although civilian public-health systems remain critical to routine helminth control.

Country Insights: Diverse Epidemiology and Health-System Priorities

Australia and Canada prioritize imported infections, Indigenous and remote-community health, veterinary interfaces, and access to specialist testing. Brazil, Mexico, India, China, and Russia face varied combinations of endemic transmission, rural access barriers, foodborne exposure, and large or mobile populations, making surveillance and locally tailored delivery important. France, Germany, Italy, Spain, and the United Kingdom combine strong diagnostic and regulatory capacity with attention to migration, travel medicine, food safety, and rare or imported infections. Japan and South Korea emphasize high-quality clinical care, laboratory confirmation, foodborne-risk management, and imported disease surveillance. Across these countries, priorities include reliable medicine supply, pediatric formulations where appropriate, resistance monitoring, and integration of treatment with prevention and sanitation measures.

Action Priorities for Leaders: Build Resilient, Evidence-Led Helminth Control

Industry and public-health leaders should align product development with documented treatment gaps, pediatric and field-use requirements, and national or international guidelines. They should strengthen quality assurance across manufacturing and distribution, maintain contingency suppliers, and support pharmacovigilance and resistance surveillance. Partnerships with ministries, laboratories, nongovernmental organizations, and community providers can improve diagnosis, adherence, and last-mile delivery. Investment in interoperable data systems, validated AI tools, and implementation research can make programs more responsive. Leaders should also measure outcomes beyond medicine distribution, including diagnostic coverage, treatment completion, adverse events, reinfection, sanitation progress, and equity of access.

Research Methodology: Evidence Triangulation Across Epidemiology, Policy, and Delivery

This executive summary uses a structured qualitative approach centered on the defined anti-helminthic-drug scope. Analysis should triangulate peer-reviewed clinical and epidemiological literature, guidance from recognized public-health and regulatory authorities, national surveillance, medicine labels, procurement and access documentation, resistance studies, and implementation research. Findings are organized by therapeutic context, geography, economic or policy grouping, and health-system capability. Regional and country interpretations should be checked against current local evidence, with uncertainty recorded where surveillance is incomplete. No unsupported numerical estimates, forecasts, market shares, or company-specific claims are used.

Conclusion: Sustainable Progress Depends on Integrated Control and Responsible Innovation

Anti-helminthic drug programs are most effective when medicines are combined with accurate diagnosis, prevention, sanitation, education, reliable supply, and long-term surveillance. Regional and national conditions differ considerably, so standardized quality and stewardship principles must be adapted to local epidemiology and delivery capacity. Responsible use of artificial intelligence, stronger resistance monitoring, and collaborative research can improve precision without weakening clinical oversight. The central strategic priority is equitable, durable control that reduces reinfection and preserves treatment effectiveness.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anti-helminthic Drugs Market, by Route Of Administration
7.1. Introduction
7.2. Oral
7.2.1. Capsules
7.2.2. Powder
7.2.3. Suspensions
7.2.4. Tablets
7.3. Parenteral
7.3.1. Intramuscular
7.3.2. Intravenous
7.3.3. Subcutaneous
7.4. Topical
7.4.1. Creams
7.4.2. Gels
7.4.3. Ointments
8. Anti-helminthic Drugs Market, by Drug Class
8.1. Introduction
8.2. Avermectins & Milbemycins
8.2.1. Ivermectin
8.2.2. Moxidectin
8.3. Benzimidazoles
8.3.1. Albendazole
8.3.2. Mebendazole
8.3.3. Thiabendazole
8.4. Imidazothiazoles
8.5. Isoquinolines
8.5.1. Niclosamide
8.5.2. Praziquantel
9. Anti-helminthic Drugs Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Injectable Solutions
9.4. Powders
9.5. Suspensions
9.6. Tablets
10. Anti-helminthic Drugs Market, by Application
10.1. Introduction
10.2. Human
10.2.1. Filariasis
10.2.2. Intestinal Nematode Infections
10.2.2.1. Ascariasis
10.2.2.2. Hookworm Infection
10.2.2.3. Tapeworm Infection
10.2.2.4. Whipworm Infection
10.2.3. Schistosomiasis
10.3. Veterinary
10.3.1. Companion Animals
10.3.1.1. Cats
10.3.1.2. Dogs
10.3.2. Livestock
10.3.2.1. Cattle
10.3.2.2. Pigs
10.3.2.3. Poultry
10.3.2.4. Sheep & Goats
11. Anti-helminthic Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Anti-helminthic Drugs Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Anti-helminthic Drugs Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Anti-helminthic Drugs Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Ajanta Pharma Limited
16.2. Alkem Laboratories Limited
16.3. AstraZeneca plc.
16.4. Aurobindo Pharma Ltd.
16.5. Bayer AG
16.6. Boehringer Ingelheim International GmbH
16.7. Cadila Healthcare Ltd.
16.8. Ceva Santé Animale S.A.
16.9. Cipla Limited
16.10. Dechra Pharmaceuticals PLC
16.11. Dr. Reddy's Laboratories Ltd.
16.12. GlaxoSmithKline plc
16.13. Glenmark Pharmaceuticals Ltd.
16.14. Ipca Laboratories Ltd.
16.15. Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
16.16. Mankind Pharma Ltd.
16.17. Merck & Co., Inc.
16.18. Norbrook Laboratories Limited
16.19. Novartis AG
16.20. Pfizer Inc.
16.21. Piramal Enterprises Ltd.
16.22. Ranbaxy Laboratories
16.23. Sanofi S.A.
16.24. Sun Pharmaceutical Industries Ltd.
16.25. Teva Pharmaceutical Industries Limited
16.26. Torrent Pharmaceuticals Ltd.
16.27. Virbac S.A.
16.28. Wockhardt Ltd.
16.29. Zoetis Inc.
16.30. Zydus Cadila (Zydus Lifesciences Limited)
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Anti-helminthic Drugs Market, Years Considered for the Study
FIGURE 2. Global Anti-helminthic Drugs Market, Research Design
FIGURE 3. Global Anti-helminthic Drugs Market, Research Framework
FIGURE 4. Global Anti-helminthic Drugs Market, Data Triangulation
FIGURE 5. Global Anti-helminthic Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Anti-helminthic Drugs Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 7. Global Anti-helminthic Drugs Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Anti-helminthic Drugs Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 9. Global Anti-helminthic Drugs Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Anti-helminthic Drugs Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 11. Global Anti-helminthic Drugs Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Anti-helminthic Drugs Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Anti-helminthic Drugs Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Anti-helminthic Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Anti-helminthic Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Anti-helminthic Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Anti-helminthic Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Anti-helminthic Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Anti-helminthic Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Anti-helminthic Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Anti-helminthic Drugs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Anti-helminthic Drugs Market Segmentation & Coverage
TABLE 2. Global Anti-helminthic Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 4. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Creams Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Creams Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Creams Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Gels Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Gels Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Gels Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ointments Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ointments Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ointments Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 44. Global Avermectins & Milbemycins Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Avermectins & Milbemycins Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Avermectins & Milbemycins Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Ivermectin Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Ivermectin Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Ivermectin Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Moxidectin Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Moxidectin Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Moxidectin Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Benzimidazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Benzimidazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Benzimidazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Albendazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Albendazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Albendazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Mebendazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Mebendazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Mebendazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Thiabendazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Thiabendazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Thiabendazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Imidazothiazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Imidazothiazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Imidazothiazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Isoquinolines Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Isoquinolines Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Isoquinolines Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Niclosamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Niclosamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Niclosamide Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Praziquantel Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Praziquantel Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Praziquantel Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 78. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Injectable Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Injectable Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Injectable Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Global Human Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Human Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Human Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Filariasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Filariasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Filariasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Intestinal Nematode Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Intestinal Nematode Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Intestinal Nematode Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Ascariasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Ascariasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Ascariasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Hookworm Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Hookworm Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Hookworm Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Tapeworm Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Tapeworm Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Tapeworm Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Whipworm Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Whipworm Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Whipworm Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Schistosomiasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Schistosomiasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Schistosomiasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Veterinary Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Veterinary Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Veterinary Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Pigs Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Pigs Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Pigs Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Sheep & Goats Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Sheep & Goats Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Sheep & Goats Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. North America Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. North America Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 175. North America Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 176. North America Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 177. North America Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 178. North America Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 179. North America Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 180. North America Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 181. North America Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 182. North America Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 183. North America Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. North America Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 185. North America Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 186. North America Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 187. North America Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 188. North America Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 189. North America Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Latin America Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Latin America Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 192. Latin America Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 193. Latin America Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 194. Latin America Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 195. Latin America Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 196. Latin America Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 197. Latin America Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 198. Latin America Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 199. Latin America Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 200. Latin America Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Latin America Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 202. Latin America Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 203. Latin America Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 204. Latin America Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 205. Latin America Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 206. Latin America Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Europe Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Europe Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. Europe Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 210. Europe Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 211. Europe Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 212. Europe Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 213. Europe Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 214. Europe Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 215. Europe Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 216. Europe Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 217. Europe Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Europe Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 219. Europe Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 220. Europe Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 221. Europe Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 222. Europe Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 223. Europe Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Middle East Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Middle East Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 226. Middle East Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 227. Middle East Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 228. Middle East Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 229. Middle East Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 230. Middle East Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 231. Middle East Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 232. Middle East Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 233. Middle East Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. Middle East Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Middle East Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 236. Middle East Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 237. Middle East Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 238. Middle East Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 239. Middle East Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 240. Middle East Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. Africa Anti-helminthic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 242. Africa Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 243. Africa Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 244. Africa Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 245. Africa Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 246. Africa Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 247. Africa Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 248. Africa Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 249. Africa Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 250. Africa Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 251. Africa Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Africa Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 253. Africa Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 254. Africa Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 255. Africa Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 256. Africa Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 257. Africa Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. Global Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. ASEAN Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. ASEAN Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 261. ASEAN Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 262. ASEAN Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 263. ASEAN Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 264. ASEAN Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 265. ASEAN Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 266. ASEAN Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 267. ASEAN Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 268. ASEAN Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 269. ASEAN Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. ASEAN Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 271. ASEAN Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 272. ASEAN Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 273. ASEAN Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 274. ASEAN Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 275. ASEAN Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. GCC Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. GCC Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 278. GCC Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 279. GCC Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 280. GCC Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 281. GCC Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 282. GCC Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 283. GCC Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 284. GCC Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 285. GCC Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 286. GCC Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. GCC Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 288. GCC Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 289. GCC Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 290. GCC Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 291. GCC Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 292. GCC Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. European Union Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. European Union Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 295. European Union Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 296. European Union Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 297. European Union Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 298. European Union Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 299. European Union Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 300. European Union Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 301. European Union Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 302. European Union Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 303. European Union Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. European Union Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 305. European Union Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 306. European Union Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 307. European Union Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 308. European Union Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 309. European Union Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 310. BRICS Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 311. BRICS Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 312. BRICS Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 313. BRICS Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 314. BRICS Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 315. BRICS Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 316. BRICS Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 317. BRICS Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 318. BRICS Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 319. BRICS Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 320. BRICS Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. BRICS Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 322. BRICS Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 323. BRICS Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 324. BRICS Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 325. BRICS Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 326. BRICS Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. G7 Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 328. G7 Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 329. G7 Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 330. G7 Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 331. G7 Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 332. G7 Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 333. G7 Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 334. G7 Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 335. G7 Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 336. G7 Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 337. G7 Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. G7 Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 339. G7 Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 340. G7 Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 341. G7 Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 342. G7 Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 343. G7 Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 344. NATO Anti-helminthic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 345. NATO Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 346. NATO Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 347. NATO Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 348. NATO Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 349. NATO Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 350. NATO Anti-helminthic Drugs Market Size, by Avermectins & Milbemycins, 2017-2032 (USD Million)
TABLE 351. NATO Anti-helminthic Drugs Market Size, by Benzimidazoles, 2017-2032 (USD Million)
TABLE 352. NATO Anti-helminthic Drugs Market Size, by Isoquinolines, 2017-2032 (USD Million)
TABLE 353. NATO Anti-helminthic Drugs Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 354. NATO Anti-helminthic Drugs Market Size, by Application, 2017-2032 (USD Million)
TABLE 355. NATO Anti-helminthic Drugs Market Size, by Human, 2017-2032 (USD Million)
TABLE 356. NATO Anti-helminthic Drugs Market Size, by Intestinal Nematode Infections, 2017-2032 (USD Million)
TABLE 357. NATO Anti-helminthic Drugs Market Size, by Veterinary, 2017-2032 (USD Million)
TABLE 358. NATO Anti-helminthic Drugs Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 359. NATO Anti-helminthic Drugs Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 360. NATO Anti-helminthic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 361. Global Anti-helminthic Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 362. United States Anti-helminthic Drugs Market Size, 2017-2032 (USD Million)
TABLE 363. United States Anti-helminthic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 364. United States Anti-helminthic Drugs Market Size, by Oral, 2017-2032 (USD Million)
TABLE 365. United States Anti-helminthic Drugs Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 366. United States Anti-helminthic Drugs Market Size, by Topical, 2017-2032 (USD Million)
TABLE 367. United States Anti-helminthic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 368. United States Anti-helminthic Drugs Market Size, by Avermectins

Companies Mentioned

  • Ajanta Pharma Limited
  • Alkem Laboratories Limited
  • AstraZeneca plc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Ceva Santé Animale S.A.
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Ipca Laboratories Ltd.
  • Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Novartis AG
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Ranbaxy Laboratories
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • Torrent Pharmaceuticals Ltd.
  • Virbac S.A.
  • Wockhardt Ltd.
  • Zoetis Inc.
  • Zydus Cadila (Zydus Lifesciences Limited)

Related Topics

Related Reports

Anti-amyloid Drugs Market - Global Forecast 2026-2032 - Product Image

Anti-amyloid Drugs Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Gout Medications Market - Global Forecast 2026-2032 - Product Image

Gout Medications Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Oral Mucositis Treatment - Global Strategic Business Report - Product Image

Oral Mucositis Treatment - Global Strategic Business Report

  • Report
  • 485 Pages
  • Global
From
Longevity and Anti-Senescence Therapy Global Market Opportunities and Strategies to 2035 - Product Image

Longevity and Anti-Senescence Therapy Global Market Opportunities and Strategies to 2035

  • Report
  • 365 Pages
  • Global
From
Anti-retroviral Drugs Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Class (Protease Inhibitors, Integrase Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs)), Regimen Type, Line of Therapy, Patient Age Group - Product Image

Anti-retroviral Drugs Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Class (Protease Inhibitors, Integrase Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs)), Regimen Type, Line of Therapy, Patient Age Group

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.